About Aquarius Bioscience

Aquarius Bioscience helps biotech and translational teams reduce costly preclinical-to-IND mistakes by providing an independent protocol and PK/PD dosing plan risk review before studies run.

We focus on clarity and outcomes: identifying gaps, assumptions, and regulatory risks early so you can fix them instead of discovering them in the clinic or at the agency.

Whether you're a startup, an academic lab, or supporting CRO oversight or VC due diligence, we deliver a structured review and actionable recommendations tailored to your stage and goals.